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The main objective of this thesis was to investigate effectiveness of local 
corticosteroid injections provided by general practitioners for the specific hand and 
wrist disorders carpal tunnel syndrome (CTS), trigger finger and de Quervain’s 
tenosynovitis. This was realized by conducting two systematic reviews of 
effectiveness of steroid injections for trigger finger and de Quervain’s tenosynovitis (a 
systematic review of effectiveness of local steroid injections for carpal tunnel 
syndrome was already published previously) and by designing three randomized 
controlled trials (RCT’s) in general practice that compared efficacy of steroid 
injections to injections with placebo for CTS, trigger finger and de Quervain’s 
tenosynovitis. Finally, a validation study investigated psychometric properties of  the 
Dutch Boston Carpal Tunnel Questionnaire, which was translated by us  into Dutch 
for use in the RCT of  efficacy of steroid injections for CTS. 
 
Chapter 1, the introduction to this thesis, provides a brief description of aetiology, 
pathophysiology and  risk factors for CTS, trigger finger and de Quervain’s 
tenosynovitis. Also the taxonomy, epidemiology and predictors of severity of hand 
and wrist disorders in general and specifically of CTS, trigger finger and de 
Quervain’s tenosynovitis are discussed. Thereafter an overview of treatment options, 
effectiveness of interventions and possible complications of treatment with local 
steroid injections for these disorders are given. Finally the objectives of this thesis are 
stated. 
 
A systematic review of effectiveness of corticosteroid injections for trigger finger in 
adults is presented in Chapter 2. The main objective of the review was to summarize 
the evidence on the efficacy and safety of corticosteroid injections for trigger finger in 
adults. For this purpose the electronic bibliographic databases CENTRAL, DARE, 
MEDLINE (1966 to November 2007), EMBASE (1956 to November 2007), 
CINAHL (1982 to November 2007), AMED (1985 to November 2007) and PEDro (a 
physiotherapy evidence database) were searched. We selected randomized and 
controlled clinical trials evaluating efficacy and safety of corticosteroid injections for 
trigger finger in adults. The databases were searched for titles of eligible studies. 
After screening abstracts of these studies, full text articles of studies which fulfilled 
the selection criteria were obtained. Data were extracted using a predefined electronic 
form. The methodological quality of included trials was assessed by using items from 
the checklist developed by Jadad and the Delphi list. We planned to extract data 
regarding information on the primary outcome measures: treatment success, 
frequency of triggering or locking, and functional impairment of fingers, severity of 
the trigger finger. Secondary outcome measures were proportion of patients with side 
effects, types of side effects, and patient satisfaction with injection. Only two small 
randomized controlled trials of poor methodological quality were found that involved 
63 participants: 34 were allocated to corticosteroids and lidocaine, and 29 were 
allocated to lidocaine alone. Both studies showed better short-term effects of 
corticosteroid injection combined with lidocaine compared to lidocaine alone on the 
treatment success outcome. Corticosteroid injection with lidocaine was more effective 
than lidocaine alone on treatment success at four weeks (relative risk 3.15, 95% CI 
1.34 to 7.40). The number needed to treat to benefit was 3. In one study the effects of 
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corticosteroid injections lasted up to four months. No adverse events or side effects 
were reported. Thus, the available evidence for the effectiveness of intra-tendon 
sheath corticosteroid injection for trigger finger can be graded as a silver level 
evidence for superiority of corticosteroid injections combined with lidocaine over 
injections with lidocaine alone, according to the grading system proposed by Tugwell. 
 
Chapter  3 contains the second systematic review, which concerns corticosteroid 
injections for de Quervain’s tenosynovitis. The main objective was to summarize 
evidence on the efficacy and safety of corticosteroid injections for de Quervain's 
tenosynovitis. The electronic bibliographic databases CENTRAL, DARE, MEDLINE 
(1966-april 2009), EMBASE (1956- april 2009), CINAHL (1982- april 2009), AMED 
(1985- april 2009), Dissertation Abstracts and PEDro (physiotherapy evidence 
database) were searched. Randomized and controlled clinical trials evaluating efficacy 
and safety of corticosteroid injections for de Quervain's tenosynovitis were selected. 
Databases were searched for titles of eligible studies. After screening abstracts of 
these studies full text articles of studies which fulfilled the selection criteria were 
obtained. Data were extracted using a predefined electronic form. The methodological 
quality of included trials was assessed by using the checklist developed by Jadad and 
the Delphi list. Data were extracted regarding information on the primary outcome 
measures treatment success, severity of pain or tenderness at the radial styloid, 
functional impairment of the wrist or hand, outcome of Finkelstein's test and the 
secondary outcome measures proportion of patients with side-effects, type of side-
effects and patient satisfaction with injection treatment. Only one small controlled 
clinical study of poor methodological quality was found, including 18 participants, 
comparing one steroid injection with methylprednisolone combined with bupivacaine 
to splinting with a thumb spica. All patients in the steroid injection group (9/9) 
achieved complete relief of pain and none of the patients in the thumb spica group 
(0/9) had complete relief of pain one to six days after intervention (NNT: 1, 95% CI 
0.8 to 1.2). No side effects or local complications of steroid injection were noted. The 
level of evidence  for superiority of steroid injections over thumb spica splinting 
could therefore be graded as silver, according to the grading system proposed by 
Tugwell. However, the applicability of these findings for daily clinical practice seems 
limited since only one study could be included in the review with only 18 participants, 
the methodological quality of the included study was poor and only pregnant and 
lactating women participated in the study.  
 
In Chapter 4 the results of the first RCT of efficacy of steroid injections for carpal 
tunnel syndrome in general practice are reported. The objective was to determine if 
corticosteroid injections for carpal tunnel syndrome provided by general practitioners 
are effective. In this study 69 participants with a clinical diagnosis of carpal tunnel 
syndrome were recruited from 20 general practices. Short-term outcomes (two weeks 
after injection treatment) were assessed in a randomized, placebo-controlled trial. 
Long-term outcomes were assessed in a prospective cohort-study of steroid 
responders during the follow-up period of 12 months. Participants were randomized to 
local injections of 1 ml triamcinolonacetonide 10 mg/ml (TCA) or 1 ml NaCl 
(placebo). Participants who had been treated with NaCl and who had no treatment 
response at short term assessment were treated with 1 or 2 additional open TCA 
injections. Main outcomes were immediate treatment success, mean score of the 
Symptom Severity Scale (SSS) and Functional Status Scale (FSS) of the Boston 
carpal tunnel questionnaire, subjective improvement and proportion of participants 
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with recurrences during the follow-up period of 12 months. At short-term assessment 
the TCA-group (n = 36) had improved more than the NaCl-group (n = 33) for 
outcomes treatment response with a number to treat of 3 (95% CI:1.83, 9.72), mean 
improvement of SSS score (0.29 vs. 0.92; p<0.05) and FSS score (-0.01 vs. 0.58; 
p<0.05) and perceived improvement (p=0.01). 49% of TCA-responders (17/35) had 
recurrences during follow-up. In the group  of TCA-responders without recurrences 
(51%, 18/35) outcomes for SSS-score and FSS-score deteriorated during the follow-
up period of 12 months (resp. p=0.008 and p=0.012). We therefore could conclude 
that corticosteroid injections for CTS provided by general practitioners are effective 
regarding short term outcomes when compared to placebo injections. The short term 
beneficial treatment effects of steroid injections deteriorated during the follow-up 
period of twelve months and half of the cohort of steroid-responders had recurrences.  
 
The results of the RCT assessing efficacy of steroid injections for trigger finger were 
described in Chapter 5. The objective was to study efficacy and safety of 
corticosteroid injections for trigger finger (flexor tenosynovitis) in adults in general 
practice. 50 adult patients presenting with a clinical diagnosis of trigger finger were 
recruited from the practices of 21 participating general practitioners in the northern 
part of the Netherlands. Short-term outcomes (two weeks after injection treatment) 
were assessed in a randomized, placebo-controlled trial. Long-term outcomes were 
assessed in a prospective cohort-study of steroid responders during the follow-up 
period of 12 months. Participants were randomized to injections of 1 ml 
triamcinolonacetonide 10 mg/ml (TCA) or 1 ml NaCl (placebo). Participants who had 
been treated with NaCl and who had no treatment response at short term assessment 
were treated with 1 or 2 additional open TCA injections. Primary outcomes were 
improvement of symptoms as perceived by the patient, improvement in symptoms not 
warranting further treatment (based on consensus agreement between patient and 
treating physician), reduction in the frequency of triggering, reduction of pain in the 
palm of the hand at the site of the affected finger and improvement in functional 
status as assessed by sub-items hand and finger function of the Dutch version of the 
Arthritis Impact Measurement Scale 2 (AIMS-2). Secondary outcomes were side-
effects of steroid injection and patient satisfaction. The TCA group did significantly 
better for all outcomes than the placebo treated group at short-term assessment. The 
short-term treatment effects were maintained in the group of steroid responders (n = 
32) during follow-up period of 12 months. There were only a few minor side-effects 
of corticosteroid treatment. We concluded that one or two local injections of 1 ml 
triamcinolonacetonide 10 mg/ml is an effective method of treatment for trigger 
fingers in general practice when compared to placebo injection. The beneficial effects 
of steroid injections lasted up to 12 months. 
 
Chapter 6 contains the report of the RCT of efficacy of steroid injections for de 
Quervain’s tenosynovitis. In this study effectiveness  of local corticosteroid injections 
for de Quervain’s tenosynovitis provided by general practitioners was assessed. 
Participants with de Quervain’s tenosynovitis were recruited by general practitioners. 
Participants were randomized to one or two local injections of 1 ml of 
triamcinolonacetonide (TCA) or 1 ml of NaCl 0.9% (placebo). Non-responders to 
NaCl were treated with additional open TCA injections. Main outcomes were 
immediate treatment response, severity of pain, improvement as perceived by 
participant, functional disability using sub items hand and finger function of the 
Dutch Arthritis Impact Measurement Scale (Dutch AIMS-2-HFF) and these were 
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measured one week after intervention and during the follow-up period of 12 months. 
Short-term outcomes (two weeks after injection treatment) were assessed in a 
randomized, placebo-controlled trial. Long-term assessment took place during the 12 
month follow-up period in an open prospective cohort-study of steroid responders. 21 
wrists in  21 patients were included by 11 general practitioners. The TCA-group had 
better results for short-term outcomes treatment response (78 % versus 25%; 
p=0.015), perceived improvement (78% versus 33%; p=0.047) and severity of pain 
(4.27 versus 1.33; p= 0.031) but not for the Dutch-AIMS-HFF (2.71 versus 1.92; 
p=0.112). Absolute risk reduction for the main outcome short-term treatment response 
was 0.55 (95% CI: 0.34, 0.76) with a number needed to treat of 2 (95% CI: 1, 3). In 
the cohort of steroid responders (n=12) the beneficial effects of steroid injections 
were sustained during the follow-up of 12 months regarding the severity of pain and 
scores of Dutch AIMS-2-HFF, but not for patient perceived improvement. No adverse 
events were observed during the 12 months of follow-up. Although the number of 
participants recruited was small, it was concluded that one or two local injections of 1 
ml triamcinolonacetonide 10 mg/ml provided by general practitioners leads in the 
short term to symptomatic improvement in participants with de Quervain’s 
tenosynovitis when compared to placebo injections. The short term beneficial effects 
of steroid injections for symptoms were maintained during the follow-up after 12 
months. 
 
In Chapter 7 the validation study for our Dutch translation of the Boston Carpal 
Tunnel Questionnaire (BCTQ) is described. The BCTQ is a validated instrument for 
assessing symptom severity and functional status in carpal tunnel syndrome. We 
translated the BCTQ into Dutch and investigated the psychometric properties internal 
consistency, responsiveness and floor and ceiling effects, using data from the 
HAWITT-trial(Chapter 4). Internal consistency was demonstrated by a Cronbach’s 
alpha of 0.86 (95% CI: 0.81-0.91) for the symptom subscale and 0.92 (95% CI: 0.88-
0.94) for the functional subscale. Responsiveness was assessed by calculating the 
standard error of measurement (SEM) which was 3.15 and minimal important change 
(MIC) which was 0.29 for the symptom subscale and respectively 2.34 and 0.29 for 
the functional subscale of the BCTQ.  
The area under the curve of the receiver operating curve was 0.80 (95% CI: 0.67-
0.92) for the symptom subscale and 0.70 (95% CI: 0.56-0.83) for the functional 
subscale using the outcome treatment response as reference standard. This means that 
the Dutch BCTQ adequately discriminates between participants who have responded 
sufficiently (based on consensus between patient and physician) to treatment and 
those  who have not. 
Minimal Important Clinical Difference (MCID) ranged from 0.50 to 0.68 for the 
symptom subscale of the BCTQ and from 0.05 to 0.31 for the functional subscale of 
the BCTQ, indicating that a change score for the Dutch BCTQ ranging from 0.50 to 
0.68 is clinically relevant for the symptom subscale and a change score ranging from 
0.05 to 0.31 is clinically relevant for the functional subscale. No significant floor or 
ceiling effects were observed. We concluded that our Dutch translation of the Boston 
Carpal Tunnel Questionnaire has appropriate internal consistency, is responsive and 
showed no floor or ceiling effects.  
 
In Chapter 8, the general discussion, the main findings of the studies reported in this 
thesis  are summarized (two systematic reviews, three RCT’s and a validation study). 
This chapter also reflects on possible implications of the findings of this thesis for the 
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practicing general practitioner regarding treatment of CTS, trigger finger and de 
Quervain’s tenosynovitis. Strengths and limitations of this thesis are discussed and 
finally recommendations for future research are made. 
 
 
 
 
